CytoArt Co-Founder Frank Li recently communicated with Prof. Martín Bonamino, President of ABTCel-Gen, regarding the booming cell and gene therapy industry across Brazil and South America.
Brazil has emerged as a global hub for decentralized & point-of-care CAR-T development. Backed by nationwide government investment in clinical translation, GMP production and regulatory construction, the country is actively exploring affordable, large-scale accessible cell therapy solutions.
Hosted in Rio de Janeiro during November 3–5, CEL-GEN 2026 is Brazil’s authoritative national CGT congress, gathering researchers, clinicians, regulators, biomanufacturers and investors across the whole industry chain. Brazil is a high-potential overlooked market for global CAR-T and advanced therapy developers.
#CellTherapy #GeneTherapy #CART #Brazil #DecentralizedCART #CELGEN2026 #AdvancedTherapies